We are live on ! Find out more
CI

Clal Insurance Portfolio holdings

AUM $16.6B
1-Year Est. Return 68.34%
This Fund
S&P 500
This Quarter Est. Return
-5.27%
1 Year Est. Return
+68.34%
3 Year Est. Return
+151.82%
5 Year Est. Return
+175.48%
10 Year Est. Return
+729.64%
AUM
$7.29B
AUM Growth
-$228M
Cap. Flow
+$351M
Cap. Flow %
4.82%
Top 10 Hldgs %
36.83%
Holding
180
New
8
Increased
35
Reduced
27
Closed
12

Sector Composition

Rank Sector Weight
1 Technology 27.16%
2 Materials 7.26%
3 Industrials 6.91%
4 Communication Services 6.76%
5 Healthcare 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACWI icon
26
iShares MSCI ACWI ETF
ACWI
$32B
$90M 1.24%
1,157,000
-154,300
-12% -$13.3M
V icon
27
Visa
V
$701B
$84.7M 1.16%
476,500
ENPH icon
28
Enphase Energy
ENPH
$4.62B
$83.8M 1.15%
302,058
+250,776
+489% +$67.6M
MA icon
29
Mastercard
MA
$498B
$82.9M 1.14%
291,500
CIEN icon
30
Ciena
CIEN
$46.8B
$71.6M 0.98%
1,770,000
+277,000
+19% +$13.3M
PGY icon
31
Pagaya Technologies
PGY
$1.35B
$69.7M 0.96%
3,340,914
-244,674
-7% -$33.9M
ICLN icon
32
iShares Global Clean Energy ETF
ICLN
$2.22B
$68.8M 0.94%
3,603,000
ACES icon
33
ALPS Clean Energy ETF
ACES
$106M
$67.9M 0.93%
1,222,850
ADBE icon
34
Adobe
ADBE
$105B
$65.5M 0.9%
238,000
+38,000
+19% +$14.4M
FLBR icon
35
Franklin FTSE Brazil ETF
FLBR
$535M
$65.2M 0.89%
3,593,000
-1,600,000
-31% -$29.1M
TWTR
36
DELISTED
Twitter, Inc.
TWTR
$62.1M 0.85%
1,416,000
-98,900
-7% -$4.03M
VRTX icon
37
Vertex Pharmaceuticals
VRTX
$123B
$61.5M 0.84%
212,240
-5,000
-2% -$1.44M
FCX icon
38
Freeport-McMoran
FCX
$86.2B
$60.4M 0.83%
2,210,000
+985,000
+80% +$28.8M
TGT icon
39
Target
TGT
$66.3B
$59.8M 0.82%
403,000
+110,000
+38% +$17.6M
FHLC icon
40
Fidelity MSCI Health Care Index ETF
FHLC
$3.35B
$58.7M 0.81%
1,019,000
KEN icon
41
Kenon Holdings
KEN
$3.33B
$58.2M 0.8%
1,685,115
-34,824
-2% -$1.43M
NOVA
42
DELISTED
Sunnova Energy
NOVA
$56.7M 0.78%
2,568,000
+300,000
+13% +$7.28M
NVDA icon
43
NVIDIA
NVDA
$4.6T
$56.7M 0.78%
4,670,000
-998,000
-18% -$15.8M
TSM icon
44
TSMC
TSM
$1.94T
$56.6M 0.78%
826,000
TAK icon
45
Takeda Pharmaceutical
TAK
$56.7B
$56.3M 0.77%
4,340,500
+2,600,000
+149% +$36.2M
ARE icon
46
Alexandria Real Estate Equities
ARE
$9.37B
$55.9M 0.77%
395,418
SPY icon
47
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$54.2M 0.74%
151,211
+9,436
+7% +$3.75M
FTNT icon
48
Fortinet
FTNT
$112B
$52.8M 0.72%
1,074,110
+1,050,000
+4,355% +$56.9M
C icon
49
Citigroup
C
$213B
$51.7M 0.71%
1,240,000
+521,000
+72% +$25.7M
BAC icon
50
Bank of America
BAC
$429B
$49.2M 0.68%
1,629,400

Similar funds

Clal Insurance's Q3 2022 Portfolio in Review

As of Q3 2022, Clal Insurance held 180 positions worth $7.29B, down 3% from $7.51B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Clal Insurance deployed $351M of net new capital in Q3 2022, opening 8 new positions and adding to 35 existing holdings. Its largest new stake was Applied Materials: 500,000 shares worth $41M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P Biotech ETF, an estimated $72.7M trimmed.

  • Clal Insurance's largest Q3 2022 buy was Applied Materials: 500,000 shares worth $41M.
  • Clal Insurance added most to SolarEdge in Q3 2022, an estimated $114M increase.
  • Clal Insurance's biggest Q3 2022 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $72.7M.
  • Clal Insurance fully exited ARK Innovation ETF in Q3 2022, selling an estimated $48M.
  • Clal Insurance's ten largest holdings make up 37% of its $7.29B portfolio in Q3 2022.
  • Clal Insurance opened 8 new positions and closed 12 in Q3 2022.
  • Clal Insurance's portfolio value fell 3% quarter-over-quarter to $7.29B.

Based on Clal Insurance's 13F filing for Q3 2022, filed 14 Nov 2022.